Dharamvir Singh Arya

9PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Te ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Plant pathologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 05, 2024
Flavonoids as therapeutics for myocardial ischemia-reperfusion injury: a comprehensive review on preclinical studies.

Vipin Kumar Verma, Priya Bhardwaj, Vaishali Prajapati

|Jul 03, 2024
Abatacept: A Promising Repurposed Solution for Myocardial Infarction-Induced Inflammation in Rat Models.

Vipin Kumar Verma, Ekta Mutneja, Salma Malik

|Feb 08, 2024
Morin ameliorates myocardial injury in diabetic rats via modulation of inflammatory pathways.

Vipin Kumar Verma, Salma Malik, Ekta Mutneja

|Jul 18, 2023
Sesamol attenuates bleomycin-induced pulmonary toxicity and fibrosis in experimental animals.

Swati Kaushik, Poorva Bhargava, Jatin Sharma

|Nov 19, 2020
Erdosteine salvages cardiac necrosis: Novel effect through modulation of MAPK and Nrf-2/HO-1 pathway.

Ekta Mutneja, Vipin K Verma, Salma Malik

|Feb 13, 2020
Attenuation of ROS-mediated myocardial ischemia-reperfusion injury by morin via regulation of RISK/SAPK pathways.

Vipin Kumar Verma, Salma Malik, Ekta Mutneja

Pageof 2